Stock ENTA ENANTA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Enanta Pharmaceuticals, Inc.

Equities

ENTA

US29251M1062

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-01 pm EDT 		5-day change 1st Jan Change
13.56 USD -1.31% Intraday chart for Enanta Pharmaceuticals, Inc. +4.95% +44.10%
Apr. 30 Enanta Pharmaceuticals, Inc. Appoints Matthew P. Kowalsky as Chief Legal Officer CI
Feb. 09 Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating MT

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ENTA Stock
  4. News Enanta Pharmaceuticals, Inc.
  5. MarketScreener Editorial Features